Lucid-21-302
Sponsors
Quantum Biopharma, Huge Biopharma Australia Pty Ltd
Conditions
Healthy ParticipantsHeathy Participants
Phase 1
Evaluating the Safety, Tolerability, Pharmacokinetics, and Effect of Food of Lucid-21-302 in Healthy Volunteers
CompletedNCT05821387
Start: 2023-03-22End: 2023-07-29Updated: 2023-08-29
Evaluating the Safety and Pharmacokinetics of Multiple Ascending Doses of Lucid-21-302 in Healthy Adult Participants
CompletedNCT06595706
Start: 2024-09-28End: 2025-01-24Updated: 2025-03-05